Literature DB >> 19793569

The hMSH2 and hMLH1 genes in hereditary nonpolyposis colorectal cancer.

Patrick M Lynch1.   

Abstract

Hereditary nonpolyposis colorectal cancer (HNPCC) is the most common inherited colorectal cancer predisposing condition. HNPCC is an important problem for the surgeon because up to 60% of carriers of mismatch repair (MMR) gene mutations develop colorectal cancer (CRC), commonly before age 50 years. When CRC is diagnosed, the surgeon is in the ideal position to order appropriate tumor testing for microsatellite instability or immunohistochemical stains for loss of MMR gene associated protein, if this has not already been done. This article reviews the history of HNPCC, its clinical features, gene discovery, development of clinical genetic workup, and clinical surveillance, with an emphasis on the two major HNPCC genes, hMSH2 and hMLH1. It is not always possible to discuss these specific genes without commenting on the broader problem of HNPCC diagnosis and management.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19793569     DOI: 10.1016/j.soc.2009.08.002

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  12 in total

1.  Aberrant methylation of different DNA repair genes demonstrates distinct prognostic value for esophageal cancer.

Authors:  Zhi-Qiang Ling; Pei Li; Ming-Hua Ge; Fu-Jun Hu; Xian-Hua Fang; Zi-Min Dong; Wei-Min Mao
Journal:  Dig Dis Sci       Date:  2011-06-15       Impact factor: 3.199

2.  Most lung and colon cancer susceptibility genes are pair-wise linked in mice, humans and rats.

Authors:  Lei Quan; Alphons P M Stassen; Claudia A L Ruivenkamp; Tom van Wezel; Remond J A Fijneman; Alan Hutson; Neelima Kakarlapudi; Augustinus A M Hart; Peter Demant
Journal:  PLoS One       Date:  2011-02-24       Impact factor: 3.240

3.  The mRNA level of MLH1 in peripheral blood is a biomarker for the diagnosis of hereditary nonpolyposis colorectal cancer.

Authors:  Hong Yu; Hui Li; Yongan Cui; Wei Xiao; Guihong Dai; Junxing Huang; Chaofu Wang
Journal:  Am J Cancer Res       Date:  2016-05-01       Impact factor: 6.166

4.  Endoscopic and surgical management of hereditary nonpolyposis colorectal cancer.

Authors:  Rebeccah B Baucom; Paul E Wise
Journal:  Clin Colon Rectal Surg       Date:  2012-06

5.  CCND1 G870A polymorphism and colorectal cancer risk: An updated meta-analysis.

Authors:  Xiao-Ming Xu; Xiao-Bing Ni; Gong-Li Yang; Zhi-Guo Luo; Yu-Ming Niu; Ming Shen
Journal:  Mol Clin Oncol       Date:  2016-04-04

6.  Incomplete Segregation of MSH6 Frameshift Variants with Phenotype of Lynch Syndrome.

Authors:  Raffaella Liccardo; Marina De Rosa; Giovanni Battista Rossi; Nicola Carlomagno; Paola Izzo; Francesca Duraturo
Journal:  Int J Mol Sci       Date:  2017-05-06       Impact factor: 5.923

7.  A Novel MLH1 Initiation Codon Mutation (c.3G>T) in a Large Chinese Lynch Syndrome Family with Different Onset Age and mRNA Expression Level.

Authors:  Yanni Zhang; Huishuang Chen; Zhiyu Peng; Santasree Banerjee; Wei Li; Zhaolong Zhao; Jianbin Sun; Jian Lv; Hui Huang; Ru Bai; Keke Lin; Zhongxin Li
Journal:  Biomed Res Int       Date:  2018-11-14       Impact factor: 3.411

8.  Genetic testing for inherited colorectal cancer and polyposis, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Rong Mao; Patti Krautscheid; Rondell P Graham; Arupa Ganguly; Suma Shankar; Matthew Ferber; Madhuri Hegde
Journal:  Genet Med       Date:  2021-06-17       Impact factor: 8.822

Review 9.  DNA mismatch repair system: repercussions in cellular homeostasis and relationship with aging.

Authors:  Juan Cristóbal Conde-Pérezprina; Miguel Ángel León-Galván; Mina Konigsberg
Journal:  Oxid Med Cell Longev       Date:  2012-11-08       Impact factor: 6.543

10.  Contribution of large genomic rearrangements in Italian Lynch syndrome patients: characterization of a novel alu-mediated deletion.

Authors:  Francesca Duraturo; Angela Cavallo; Raffaella Liccardo; Bianca Cudia; Marina De Rosa; Giuseppe Diana; Paola Izzo
Journal:  Biomed Res Int       Date:  2012-12-30       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.